WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2016> 32> 10

Volume: 32 Issue: 10

1. Current status of diagnosis and treatment of primary biliary cholangitis and related challenges in China Page:1833—1837
2. Features of immune response during antiviral therapy in patients with chronic hepatitis B Page:1858—1862
3. Innate immune response and acquired immune response in patients with chronic HBV infection Page:1863—1869
4. Related immune manifestations in patients with chronic hepatitis B virus and chronic hepatitis C virus infection Page:1870—1873
5. Advances in immunological treatment of autoimmune hepatitis Page:1874—
6. Influence of hepatitis B virus infection on intrahepatic natural killer cells and innate lymphoid cell 22 Page:1883—1887
7. Bone marrow mesenchymal stem cell transplantation via different approaches in treatment of liver cirrhosis in mice Page:1906—1910
8. Clinical effect of albumin-bound paclitaxel in treatment of advanced primary liver cancer Page:1911—1915
9. Clinical effect of laparoscopic versus open liver resection in treatment of patients with hepatocellular carcinoma complicated by liver cirrhosis Page:1916—1919
10. Application of spiral CT and ultrasound in diagnosis of hepatic adenoma Page:1925—1928
11. Clinical effect of ultrasound-guided percutaneous transhepatic gallbladder drainage in treatment of acute cholecystitis in elderly patients Page:1929—1931
12. Risk factors for acute liver failure after radical surgery combined with hemihepatectomy for hilar cholangiocarcinoma Page:1936—1938
13. Clinical value of serum C-reactive protein, procalcitonin, and lipase in predicting severe acute pancreatitis during pregnancy Page:1939—1942
14. Mechanism of action of recombinant interleukin-2 combined with allicin in treatment of pancreatic cancer Page:1943—1946
15. Effect of Qianggan capsules on insulin resistance index and liver fibrosis score in patients with nonalcoholic fatty liver disease Page:1951—1954
16. Serum levels of adiponectin and ferritin and their clinical significance in patients with nonalcoholic fatty liver in Qinghai, China Page:1955—1958
17. Postoperative complications of laparoscopic versus open common hepatic duct-jejunal Roux-en-Y anastomosis: a Meta-analysis Page:1959—1963
18. Endoscopic therapy for gastrointestinal bleeding after liver transplantation Page:1964—1966
19. Research advances in immunotherapy for chronic hepatitis B Page:1984—1988
20. Association of chronic hepatitis B with interferon-γ and interleukin-4 Page:1989—1993
21. Roles of regulatory T cells and T-helper cells in hepatitis B virus-related liver diseases Page:1994—1997
22. Clinical identification and management of chronic HBV carriers Page:1998—2000
23. Role of circulating microRNAs in development and progression of liver fibrosis Page:2001—2003
24. Research advances in venous thromboembolism in patients with liver cirrhosis Page:2004—2006
25. Concept of fast-track surgery and its application in perioperative period of hepatectomy for liver cancer Page:2007—2011
26. Research advances in MRI features and diagnosis of hepatocellular adenomas Page:2012—2015
27. Advances in diagnosis and treatment of primary biliary cholangitis Page:2016—2020
28. Current status of diagnosis and treatment of IgG4-related sclerosing cholangitis Page:2021—2025
29. Research advances in molecular targeted therapy for pancreatic cancer Page:2026—2028

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.